XLO
Xilio TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
XLO vs peer average
62/100
XLO vs. peer average (C vs. D)
Grade spread
A 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
GANX is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $51.94M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XLO
Xilio Therapeutics
GANX
Gain Therapeutics
Grade
C
C
Momentum
29
82
Value
56
41
Sentiment
-
57
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs GANX
XLO / GANX
Grade Position
In line
XLO vs. peer average (C vs. D)
62/100
Momentum
29
GANXValue
56
XLOSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XLO
GANX is the first peer returned for this comparison set.